Marina

With its “Maternity Leave” and “Re-Entry” programs, RESIST provides targeted support for female researchers striving to balance pregnancy, family life, and demanding scientific work. Two examples from dermatology and pediatric pulmonology illustrate how this support makes a tangible difference. Continuity in the Laboratory: Support for Dr. Rebecca Pospich Dr. rer. nat. Rebecca Pospich conducts research at the Department of Dermatology, Allergy and Venereology under the supervision of Prof. Dr. Thomas Werfel and PD Dr. Lennart Rösner. Her scientific focus lies in the investigation of patient samples from atopic dermatitis and cutaneous T-cell lymphoma. Her work regularly involves bacterial pathogens [...]

A team from the Institute of Virology delivered a strong team performance at this year’s marathon in Hanover: competing under the name “Infectious Pace,” Lucas Mendes Monteiro, Josi Schenk, Carolin Vogt, Santiago Álvarez Cárdenas, Abel Viejo-Borbolla, and Xiangming Han completed the race together in 4 hours, 10 minutes, and 43 seconds. All team members are affiliated with the Institute of Virology and work on various aspects of viral infections. Lucas Mendes Monteiro and Josi Schenk are PhD students of RESIST member Prof. Dr. Abel Viejo-Borbolla and focus on varicella-zoster virus (VZV), studying immune modulation and cellular metabolism. Carolin Vogt [...]

The RESIST Cluster of Excellence has elected two new representatives for the YOUNG RESIST committee: PD Dr. Stephan Traidl will take on the role of postdoc representative, while Isabel Klefenz will represent the interests of doctoral students. Both bring not only solid scientific expertise but also a strong commitment to networking and interdisciplinary collaboration. Stephan Traidl studied medicine at Hannover Medical School (MHH) and received support during his studies through several scholarships, including the German National Academic Foundation and the Hannover Biomedical Research School (HBRS). International stays in Switzerland, the United Kingdom, and the United States, particularly in the [...]

Researchers at Hannover Medical School (MHH) have developed a method for efficiently producing human immune cells, such as macrophages, in medium-sized bioreactors. The immune cells can be derived from induced pluripotent stem cells and are important for disease research as well as for new therapeutic approaches. The method has now been published in the journal Nature Protocols. Macrophages—also known as “scavenger cells”—play a central role in the human immune system. They are indispensable for defending against pathogens and for repairing damaged tissue. Furthermore, they are already being used in clinical therapy, for example in the treatment of liver diseases. [...]

Since the beginning of RESIST’s second funding phase in early 2026, Prof. Dr. Anna-Maria Dittrich has joined the research consortium. She is Professor of Translational Pediatric Pneumology at Hannover Medical School and a senior physician in Pediatric Pneumology and Allergology. In addition, she heads the Pediatric Cystic Fibrosis Center and serves as co-director of the Christiane Herzog Center for Cystic Fibrosis. Prof. Dittrich’s research focuses on cystic fibrosis, particularly on immunological and inflammatory processes as well as infections, which she investigates, among other methods, using metagenomic analyses. Within RESIST, she studies how host genetic risk factors and the pathogenicity [...]

A recent study from Hannover, conducted within the framework of the Excellence Cluster RESIST, provides important insights for understanding and the future treatment of chronic hepatitis B. Researchers from Hannover Medical School (MHH), the Helmholtz Centre for Infection Research (HZI), TWINCORE, and the Centre for Individualised Infection Medicine (CiiM), a joint institution of HZI and MHH and a core component of RESIST, have demonstrated that a previously underappreciated group of immune cells, known as γδ T cells, plays a central role in controlling viral infection. The study was published in the journal Gut. γδ T cells are capable of [...]

The Cluster of Excellence RESIST played a key scientific role at the 2nd International Conference on Individualised Infection Medicine in Hanover. The conference, held from March 19 to 21, 2026, at Herrenhausen Palace, brought together around 160 international experts from research and clinical practice to discuss new approaches to the prevention, diagnosis, and treatment of infectious diseases. With its own scientific session, RESIST was prominently represented in the program, underlining its key role in researching infection resistance and developing innovative therapeutic strategies. Chaired by Prof. Dr. Kathrin de la Rosa, the session provided diverse insights into the cluster’s current [...]

Since the beginning of RESIST’s second funding phase in early 2026, Prof. Dr. Thomas Skripuletz has been part of the research consortium. The neurologist has headed the Laboratory for Cerebrospinal Fluid Diagnostics and Neurochemistry at Hannover Medical School since 2021 and contributes extensive expertise in the study of neuroimmunological diseases. His work within RESIST focuses on severe virus-associated diseases of the central nervous system in immunocompromised patients, particularly progressive multifocal leukoencephalopathy (PML), which results from reactivation of the JC polyomavirus. The aim of his research is to better understand why some patients benefit from virus-specific T-cell therapies while others [...]

The Europe-wide education event UniStemDay once again inspired thousands of students to engage with stem cell research on March 20, 2026, including at the Hannover Medical School (MHH). The event, held in Germany since 2016 and now organized worldwide, brought together over 35,000 participants this year across more than ten European countries and additional international locations. In Hannover, around 28 students from the city and surrounding region took part and gained an exclusive insight into current medical research and clinical practice. The day was organized by RESIST Prof. Lachmann, PD Dr. Ruth Olmer, and Dr. Sylvia Merkert, with support [...]

On March 12, 2026, the first orientation event for the YOUNG RESIST program took place in a hybrid format. The initiative brings together a total of 95 young RESIST researchers, including doctoral candidates, early-career postdocs, and clinical scientists, with the goal of strengthening networking among early-career researchers in the RESIST Cluster of Excellence, promoting their development, and creating additional opportunities for active participation. The participants were welcomed by Prof. Dr. Reinhold Förster, Head of Immunology and Spokesperson for the RESIST Cluster of Excellence. Project Coordinator Dr. Eugenia Gripp led the program. At the start of the event, the cluster’s [...]